[
  "Dennis Gillings is the founder and former CEO and chairman of clinical research firm Quintiles Transnational, which changed its name to IQVIA in 2017.",
  "Gillings, a former biostatistics professor, launched Quintiles in 1982 with the goal of making clinical trials for drugs faster and more efficient.",
  "Gillings retired from the board of IQVIA in April 2018. He still serves as a partner of healthcare-focused investment firm NovaQuest Capital.",
  "In November 2019, NovaQuest finished raising $275 million for its first private equity fund. The firm manages about $2.5 billion in total assets.",
  "Quintiles reached annual revenues of $5.7 billion before merging with healthcare data firm IMS Health in 2016."
]